Integration, Robotics, and Automation
The integration of instruments and technology is a key concept driving the development of advanced laboratory automation. Caliper Life Sciences recently announced its acquisition of Xenogen, a maker of imaging instruments and software. Caliper's expertise lies in microfluidic technology and automation, and the acquisition provides imaging technology critical for in vitro and in vivo analyses in drug discovery and biomarker research.
Late last year, when Caliper acquired NovaScreen BioSciences, a life science services company based in Hanover, Md., it took another step towards integration, combining NovaScreen's screening, profiling, and assay development services with its own LabChip and liquid-handling technology. The ultimate aim for all providers of automated instrumentation for drug discovery is to provide a "one-stop shop" for drug developers, through the development of fully integrated systems that incorporate biological assays, instrumentation, software, and even sample and reagent storage and handling.
For example, in January, NovaScreen launched the KinaseAdvisor screening panel of 48 protein kinase assays, which is designed for use on the Caliper LabChip 3000 platform, a drug discovery system that miniaturizes, integrates, and automates enzymatic and cell-based assays. As 75 percent of the top 15 pharmaceutical companies are already using Caliper systems in their screening efforts, the new assay should be accessible for integration by many top drug developers. Another advantage of integration is a reduced need for technical staff, as more aspects of biological screening are automated and coordinated, allowing for much greater "walk away" time for operators of the systems.
Lab Feng Shui
A further advantage of integration is the optimization of limited laboratory space. In January, Thermo Electron launched the HCS WorkCell, a high-content screening system with a small "footprint." The use of fluorescent microscopy has given rise to screening tools based on high-resolution imaging of multiple targets within a cell. These systems present information on multiple spatial and temporal events in cells and offer significant advantages over fluorescent plate readers used in conventional cell-based assays because they measure multiple signals from individual cells within a well as opposed to a single signal per well. A typical system consists of imaging instrumentation, fluorescent reagents, probes, and software and can be fully automated using multiwell and robotic sampling systems. This approach is more efficient for validation of cellular targets and predictive toxicology and lead optimization.
The HCS WorkCell is characterized by vertical integration — hence the small footprint — so as to deliver a compact automated system that is easy to relocate and frees up lab floor space. Components are essentially stacked as opposed to arranged horizontally, maximizing valuable bench space. Thermo is marketing the system as ideal for cell-based analysis for applications such as stem cell research, cell growth, toxicity assays, and siRNA technology. The HCS WorkCell operates with Thermo's Orchestrator software, a workflow optimization tool that can connect the flow of information from automation scheduling software to a LIMS database.
More sophisticated robotics are also increasingly being integrated into automated systems. Beckman Coulter is a provider of automated and integrated laboratory systems, focused primarily on the Biomek line of liquid handlers. Early this year, Beckman Coulter announced the selection of the Motoman (a Yaskawa company) industrial robot arm for integration with the company's automated liquid-handling products, providing drug discovery/screening and sample prep customers with an industrialized option for ultra-high throughput.
Beckman Coulter's Sagian automated core system incorporated a Biomek workstation and is designed to improve productivity in high-throughput screening labs by simplifying and standardizing complex robotic operations. Its SAMI software offers a menu of "plug-and-play" systems that can be reconfigured for new technology and assays. The Motoman robot will join Beckman Coulter's own Orca and Robotic Transport (BRT) robotics to give customers a choice of automation scalability. The Motoman robot, rail setup, and software controls will be optimized for use with Biomek FX or NX automated liquid-handling systems and integrated solutions.
E-mail Robert M. Frederickson at [email protected].
PerkinElmer Enhances Janus Automated Workstation
PerkinElmer recently announced new capabilities for its Janus Automated Workstation platform. Unveiled at LabAutomation 2006, which took place in January 2006 in Palm Springs, California, the Janus platform includes features and functionalities for future adaptability in throughput, capacity and dynamic volume range for automated liquid handling applications.
Janus is a modular and scalable liquid handling device that forms the cornerstone of PerkinElmer's Packard Automation and Liquid Handling products. The Janus MDT Automated Workstation is a 96- or 384- channel workstation offering Modular Dispense Technology (MDT) with interchangeable dispense heads, including the NanoHead, which enables assay miniaturization with 384-tip processing down to 50 nL with coefficients of variation better than 13 percent. MDT allows customers to automatically program the selection of numerous dispense heads and formats to provide hands-off adaptability in dynamic volume range and microplate densities up to 1536 wells.
The Gripper Integration Platform is a third arm labware movement option, available on most versions of Janus. It provides comprehensive labware movement within the Janus deck, as well as to external devices, including plate readers and shakers.
The Mini-Janus Automated Workstation offers a single arm option with a smaller nine-position deck that includes the MDT interchangeable pipetting head system for automated pipetting into 96-, 384-, and 1536-well microplates.
The aim of the Janus product line is to allow the addition and replacement of liquid handling and labware movement functionality as application and throughput demands evolve. The platform allows for up to three arms for dispensing and labware movement, with full upgradeability to address future assay changes and scaling. The modular design delivers real-time and future adaptability in throughput, capacity, and dynamic volume range. Finally, Janus includes 4- and 8-tip pipetting capability plus 96- or 384-tip MDT dispense head options in a single platform for optimal precision pipetting and performance.
: Featured Events : |
Upcoming Industry Events
The 2nd Annual Text Analytics Summit 2006 - June 22 - 23, Hilton Back Bay, Boston USA Following the massively successful Text Mining Summit 2005, the 2nd Annual Text Analytics Summit 2006 will bring together leading-edge developers and tech-savvy users of text analytics technology. Users and developers will meet in order to discuss:latest developments in text analytics technology;leveraging text analytics enterprise-wide;lucrative emerging applications for text analytics; + much more. Free Ticket Offer We have 2 free tickets to give away to Bio-IT World Subscribers – simply go to www.textanalyticsnews.com/freeticket/bio to enter the prize draw! For further info, visit www.textanalyticsnews.com/bio, call Ravi Virpal on +44 (0) 20 7375 7162 or email [email protected]
Life Sciences Conference + Expo - April 3 - 5, Boston, MA The Life Sciences Conference + Expo features an outstanding program of keynotes, three-day conference tracks, educational workshops, exhibit floor, and award programs and special events. Speakers will discuss the latest technology developments and research breakthroughs on the complete spectrum of topics involved in drug discovery through market delivery. Learn from actual case studies and panel presentations on how the leading pharma and biotech companies utilize IT and informatics to enhance drug process and speed the time to market. Find out more today at: http://www.lifesciencesexpo.com
Stability Programs - June 8 - 9, Princeton, NJ https://www.cbinet.com/show_conference.cfm?confCode=HB653 CBI is pleased to announce the 2006 Stability Programs Summit, which features new, elevated content and a distinct focus on pressing stability regulatory requirements. This conference convenes leaders from key regulatory agencies and leading case studies to map out the next steps in meeting various stability testing requirements as set by ICH, FDA, ASEAN, WHO, and EMEA. Attend to learn how to best implement a stability testing program, how to evaluate the tools and technology available and gain insight into the various methods for stability data analysis.
Bio-IT World Best Practices - Call for Entries - Deadline: April 7th Bio-IT World is now seeking submissions to its 2006 Best Practices Awards Program. This annual Best Practices Awards Program attracts an elite group of life science professionals: executives, entrepreneurs, cutting-edge innovators and others responsible for developing and implementing innovative solutions for streamlining the drug development and clinical trial process. The winners and entrants will be featured in a Special Report published in Bio-IT World, and invited to attend a gala Awards Announcement reception, held during the annual DIA conference.Find out more at www.bio-itworld.com/bestpractices/2006
MIT PROFESSIONAL INSTITUTE – SUMMER SESSION 2006 The Massachusetts Institute of Technology is currently accepting registrations for 35 intensive, week-long programs designed especially for professionals. Courses taught on campus by MIT faculty from June through August. Earn a certificate and CEUs. Offerings include biotechnology, chemical engineering, energy, IT, mechanical engineering, nanotechnology, physics, technology policy, system architecture, and other topics of vital interest to today's engineers and scientists. Visit our website to register and view course descriptions. http://web.mit.edu/mitpep/ads/pi-bioit-may.html
CBI's Drug Development – From Animal Models to Phase I; Pursue Quality Leads by Expediting PK/PD and Efficacy Data Collection -- April 10 - 11, 2006, Philadelphia, PA Expediting drug development is a major concern for the pharmaceutical industry. Maximizing preclinical and early clinical development not only speeds up the process, but also reduces money wasted on pursuing compounds with little or no potential for approval. The purpose of this event is to bridge the gap between preclinical and Phase I development. High level speakers present crucial solutions ranging from developing new humanized transgenic animal models to designing more efficient Phase I trials. For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at [email protected]. Visit: https://www.cbinet.com/show_conference.cfm?confCode=HB637
|
|